Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EHMT2 | Q96KQ7 | 4/20 | 0.59 |
| ▸ | HDAC4 | P56524 | 3/20 | 0.45 |
| ▸ | HDAC1 | Q13547 | 3/20 | 0.45 |
| ▸ | NAMPT | P43490 | 7/20 | 0.45 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.44 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.44 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.44 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.44 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.44 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.44 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.44 |
| ▸ | HDAC9 | Q9UKV0 | 1/20 | 0.44 |
| ▸ | HDAC5 | Q9UQL6 | 1/20 | 0.44 |
| ▸ | DYRK1A | Q13627 | 4/20 | 0.41 |
| ▸ | GSK3B | P49841 | 2/20 | 0.41 |
| ▸ | MAPK7 | Q13164 | 1/20 | 0.41 |
| ▸ | CTSS | P25774 | 1/20 | 0.41 |
| ▸ | CTSK | P43235 | 1/20 | 0.41 |
| ▸ | CLK2 | P49760 | 2/20 | 0.41 |
| ▸ | CLK3 | P49761 | 2/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26086765 | 0.85 | EHMT2 (0.57) | EHMT2NAMPTCTSSCTSK | |
| SCHEMBL23448624 | 0.84 | EHMT2 (0.58) | EHMT2NAMPTDYRK1AGSK3BMAPK7 | |
| SCHEMBL26090547 | 0.84 | EHMT2 (0.59) | EHMT2NAMPTDYRK1AMAPK7CLK2 | |
| SCHEMBL26436950 | 0.83 | EHMT2 (0.58) | EHMT2NAMPTDYRK1AGSK3BMAPK7 | |
| SCHEMBL26436929 | 0.83 | EHMT2 (0.58) | EHMT2NAMPTDYRK1AGSK3BMAPK7 | |
| SCHEMBL26090016 | 0.83 | HDAC4 (0.52) | EHMT2HDAC4HDAC1HDAC3HDAC7 | |
| SCHEMBL26436938 | 0.83 | EHMT2 (0.59) | EHMT2NAMPTDYRK1AGSK3BMAPK7 | |
| SCHEMBL23449166 | 0.82 | EHMT2 (0.56) | EHMT2NAMPTDYRK1AGSK3BMAPK7 | |
| SCHEMBL26436940 | 0.82 | EHMT2 (0.57) | EHMT2NAMPTDYRK1AGSK3BMAPK7 | |
| SCHEMBL26436905 | 0.82 | EHMT2 (0.60) | EHMT2NAMPTHDAC3HDAC8DYRK1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230127046-A1 | G9a INHIBITOR | RIKEN (JP) | 2023-04-27 | — | — | US | disclosed |
| US-20230127046-A1 | G9a INHIBITOR | RIKEN (JP) | 2023-04-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230127046-A1 | G9a INHIBITOR | EZH2, BMI1, DOT1L | EHMT2 8/4885HDAC4 237/4885HDAC1 38/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.